GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (NAS:MNKD) » Definitions » Shiller PE Ratio

MannKind (MannKind) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is MannKind Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MannKind Shiller PE Ratio Historical Data

The historical data trend for MannKind's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Shiller PE Ratio Chart

MannKind Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MannKind Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MannKind's Shiller PE Ratio

For the Biotechnology subindustry, MannKind's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MannKind's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MannKind's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MannKind's Shiller PE Ratio falls into.



MannKind Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MannKind's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, MannKind's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.01/129.4194*129.4194
=0.010

Current CPI (Dec. 2023) = 129.4194.

MannKind Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.700 99.695 -0.909
201406 -0.950 100.560 -1.223
201409 -0.450 100.428 -0.580
201412 -0.450 99.070 -0.588
201503 -0.400 99.621 -0.520
201506 -0.350 100.684 -0.450
201509 -0.400 100.392 -0.516
201512 -3.300 99.792 -4.280
201603 -0.290 100.470 -0.374
201606 -0.330 101.688 -0.420
201609 1.310 101.861 1.664
201612 0.560 101.863 0.711
201703 -0.170 102.862 -0.214
201706 -0.350 103.349 -0.438
201709 -0.310 104.136 -0.385
201712 -0.280 104.011 -0.348
201803 -0.250 105.290 -0.307
201806 -0.160 106.317 -0.195
201809 -0.160 106.507 -0.194
201812 -0.040 105.998 -0.049
201903 -0.080 107.251 -0.097
201906 -0.070 108.070 -0.084
201909 -0.050 108.329 -0.060
201912 -0.070 108.420 -0.084
202003 -0.040 108.902 -0.048
202006 -0.050 108.767 -0.059
202009 -0.050 109.815 -0.059
202012 -0.110 109.897 -0.130
202103 -0.050 111.754 -0.058
202106 -0.140 114.631 -0.158
202109 -0.020 115.734 -0.022
202112 -0.110 117.630 -0.121
202203 -0.100 121.301 -0.107
202206 -0.110 125.017 -0.114
202209 -0.060 125.227 -0.062
202212 -0.070 125.222 -0.072
202303 -0.040 127.348 -0.041
202306 -0.020 128.729 -0.020
202309 0.010 129.860 0.010
202312 0.010 129.419 0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MannKind  (NAS:MNKD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MannKind Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MannKind's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind (MannKind) Business Description

Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Executives
Michael Castagna officer: Chief Commercial Officer 25134 RYE CANYON LOOP, SUITE 300, VALENCIA CA 91355
David Thomson officer: VP & Assoc General Counsel 28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Steven B. Binder officer: Chief Financial Officer 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
Burkhard Blank officer: EVP Chief Medical Officer C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Lauren M Sabella officer: EVP Chief Operating Officer C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Sanjay R Singh officer: EVP Technical Operations 1 CASPER STREET, DANBURY CT 06810
Alejandro Galindo officer: Chief Commercial Officer 30930 RUSSELL RANCH RD, STE 300, WESTLAKE VILLAGE CA 91362
Stuart A Tross officer: Corp VP, Chief People Officer ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Anthony C Hooper director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Jennifer Grancio director 30930 RUSSELL RANCH ROAD SUITE 300, WESTLAKE VILLAGE CA 91362
Christine Mundkur director
Sabrina Kay director 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
David M Kendall officer: Chief Medical Officer 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362
Patrick Mccauley officer: Chief Commercial Officer 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
Barton Courtney officer: Chief Compliance Officer 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362